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Strengthening the UK primary care response to covid-19
More emphasis on primary care in the management of covid-19 would improve outcomes for patients
argue Sophie Park and colleagues
Sophie Park, 1 Josephine Elliott, 2 Anita Berlin, 3 Julia Hamer-Hunt, 4 Andy Haines5
Health services across the world made rapid
adjustments to the direct and indirect consequences
of covid-19 with varying success.1 The World Health
Organization’s initial recommendations were based
on system adaptations in China, focusing
predominantly on secondary care and public
health.2 3 Primary care received less policy attention
both globally and in the UK.
Hospitals were major centres of transmission, with
mortality at 40% among those receiving critical care4
and many patients dying alone. With cases again
increasing, there is an urgent need for strategies to
support management of patients at home, reduce
unnecessary admissions, and optimise the use of
health service resources.
Effect on UK primary care
Rapid changes in response to covid-19 had profound
effects on delivery of primary care in the UK. For
example, telephone, email, and video consultations
increased substantially.5 This allowed continuity of
care but meant that only selected patients received
face-to-face consultations, such as those for whom
physical examination was expected to significantly
change management and the potential benefit
outweighed the risks.
Patients with symptoms of covid-19 were redirected
to NHS 111 call centres to access testing. Although
use of NHS 111 shifted the immediate burden of
diagnosing and managing patients with covid-19, it
also undermined the ability of general practice to
provide continuing and comprehensive care. Call
centre staff do not have full access to patient records
and so have limited information about the patients’
coexisting conditions andhome situation. As 111 staff
focused on acute covid-19 symptoms, patients were
often denied the opportunity to discuss long term
care options for covid-19 andother serious conditions
with a familiar healthcare professional.
Many patients in care homes are looked after by GPs.
The shift to remote working resulted in inconsistent
support for care homes, which was compounded by
inadequate personal protective equipment and
disorganised testing of staff and residents. The
government support package was published late (15
May 2020),6 resulting in missed opportunities to
prevent infection in residents and staff.
Current challenges
These initial changes have now become normalised.
Although patients with severe symptoms were still
admitted tohospitals, during the summer, about 30%
of registered covid-19 deaths occurred outside
hospitals.7 For example, data from the Office for
National Statistics (ONS) for the week ending 3 July
2020 shows that deaths in private homes were above
the five year average. Primary care is therefore faced
with new challenges.
Covid-19 is moving into a long term pattern with
repeated infection peaks and local outbreaks. People
who survive the initial covid-19 infection can
experience severe mental and physical sequelae.
Lockdownand the resulting economic recessionmay
also exacerbate chronic mental, social, and physical
health problems (fig 1). General practices must
therefore plan, risk assess, and provide care for both
covid-19 and the accumulating backlogs of other
acute and chronic disease. This requires monitoring
systems for covid-19 and non-covid morbidity with
surge capacity for the flu season and local outbreaks.
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Fig 1 | Illustration of four types of effect of covid-19 (adapted from Victor Tseng, Emory University, with permission). Each effect peaks at different times, potentially repeating
with subsequent surges. Peaks may vary in timing and magnitude by location
In addition, ensuring good palliative care is important for patients
who will not benefit from intense medical intervention and requires
an appreciation of the process and rituals of dying,8 alongside
practical guidance, such as discussion of power of attorney. It
benefits fromGPs’knowledgeof patients andcarers, regular contact,
planning, and coordination between patients, primary, and
palliative care services.
The gap between public health and primary care has also been
exposed by covid-19. Public health is integrated with local
government and is largely disconnected from primary care,
resulting, for example, in poor health protection inmany residential
care homes. The challenge is compounded by the initial
marginalisation of public health in testing and contact tracing,
which has been outsourced to private companies rather than
strengthening existing services.9 This has undermined a coherent
response. The formation of the National Institute for Health
Protection will bring together Public Health England, the NHS test
and trace service, and the Joint Biosecurity Centre, but the links
with primary care and the plans for the broader preventive activities
of Public Health England are unclear.10
Primary care is therefore facing interlinked problems: inadequate
notification of covid-19 test results; delayed investigation or
admission of sick patients; inadequate discharge planning and
communication; inappropriate admission of thosewhoare unlikely
to benefit; and the need for enhanced, complex care of chronically
ill people in community settings. The extent to which these
challenges will persist after the initial wave of infections remains
to be seen.
Primary care is inadequately represented at the strategic level. For
example, there are no practising GPs on any Scientific Advisory
Group for Emergencies (SAGE) committee. Instead, communication
has been predominantly downwards from (mostly national rather
than local) public health and specialist care. Another example is
the initial compilation of lists of “clinically extremely vulnerable”
patients for shielding, which was largely derived from hospital
records as these were wrongly assumed to be the most accurate
source of clinical information. Lists were then circulated to GPs for
checking with little notice over the Easter weekend. Our experience
suggests that many patients were initially incorrectly classified.
Potential responses
UK general practice is embedding new models of care to help
patientswith an increasingly complexburdenof ill health, alongside
rapid changes in service delivery. The risk is that these ways of
working become (by default) accepted and fixed without any
strategic thought.
GPs must be part of a coherent strategy that prepares the NHS for
covid-19 outbreaks, concomitant epidemics, and delayed
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management of other conditions. Prompt communication between
primary care, public health, and secondary care is essential. Some
public health expertise has been integrated into clinical
commissioning groups and their primary care networks, but this
should be extended to testing and contact tracing. Resilient supply
chains for essential equipment, including personal protection,
technologies for remote monitoring, and opportunities for bedside
or same day testing are imperative.
Robust strategies areneeded tooptimise themanagementof patients
with covid-19 at home, including end-of-life support for those who
are not candidates for intensive care. Joint plans can be developed
for more humane care with family involvement.
Hospital at-home services and community nursing should be scaled
up for both covid-19 and non-covid conditions to reduce pressure
on hospital beds. In care homes, staff have already adapted
processes to improve advanced care planning while minimising
unnecessary physical contact. This includes video ward rounds,
electronic stethoscopes, pulse oximeters, and allowing staff to
confirm death.
To deal with rising demand, there will be a transition from nearly
100% virtual consultations to an appropriate mix of virtual and
face-to-face consultations. While telemedicine has proved
invaluable, it has limitations; touch is an important aspect of patient
assessment and care,11 and patient suitability for remote consulting
varies.12 Care should also be taken to ensure that efforts to promote
the use of online tools to access key information do not undermine
equity of access and continuity. People recovering from covid-19
also need access to rehabilitation, monitoring of respiratory and
other affected systems, and mental health support.
Primary care will also have to deliver massive expansion of the flu
prevention programme as well as future covid-19 vaccinations. The
training of new healthcare professionals must be adapted to this
altered service environment. This requires patient involvement and
systematic long term evaluation of impact.
Priorities for research
We urgently need greater investment in primary care research. The
pandemic provides opportunities to evaluate early clinical
interventions and the rapid introduction of potentially long term
change in services and providers. The safety and effectiveness of
near patient technologies in the community requires rigorous
evaluation. These include wearable sensors to monitor vital signs
and home testing for D dimer13 or other predictors of increased
hospital mortality.
There is also potential to trial approaches from other countries. For
example, community healthworkers,when integratedwithprimary
care, could undertake a range of assessment, health promotion,
and monitoring roles in the UK.14 Community health workers were
important in controlling Ebola outbreaks in west Africa and the
Democratic Republic of Congo, and may also have roles in
enhancing health education and reducing covid related stigma.15
Studies using large primary care databases linked to hospital data
give the best prospect of understanding prognostic and risk factors
for acquiring the infection. They canalsodetect potential candidates
for drug trials and, conversely, hazardous drugs. The OpenSAFELY
platform linking (anonymised) primary care electronic health
records to data on covid-19 deaths in hospital is enabling
identification of risk factors for death in a representative population
of over 17 million patients.16 If GPs are routinely notified of all
patientswith covid-19, itwould also bepossible to assess risk factors
for infection and the long term outcomes.
Trials of early intervention in covid-19 are needed to prevent
deterioration and hospital admission. Some treatments, such as
antivirals andmonoclonal antibodies, aremore likely to be effective
in early disease.17 Current hospital trials may therefore give an
unrepresentative view of their potential effect on outcomes. Only
five of the 33 WHO registered covid-19 studies relate to primary care,
and there is currently only one UK registered study of primary care
covid-19 treatment in the UK (the PRINCIPLE study).18 It is a well
designed, adaptive trial that assesses the effectiveness of
azithromycin in high risk patients. GPs, if integrated into the
covid-19 response and informed of patients’ test results, could
increase recruitment to these trials.
Joined-up care
Individual and organisational efforts to respond to covid-19 have
been rapid and extraordinary. They have, however, lacked a
connected, coherent strategy. Primary care offers opportunities for
early intervention to reduce the risk of adverse outcomes, continuity
of care, and enhanced whole system resilience in response to a
range of health challenges arising from the evolving covid-19
pandemic. Effective technical and human responses require direct
involvement of primary care in planning and implementing service
changes and appropriate training, underpinned by robust research
evidence.
Key messages
• The potential contribution of primary care has been largely overlooked
in the UK’s response to covid-19
• Active engagement of primary care will be essential to improve care
of vulnerable patients in the community; reduce demands on hospital
services; support rehabilitation of recovering patients; improve
palliative care; and sustain non-covid care
• Well designed trials of early treatment of covid-19 in primary care
should be a priority for research funding
• Additional primary care research would strengthen the capacity of
primary care to deal with the backlog of non-covid morbidity and the
physical and mental health sequelae of the pandemic
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